Annual Total Liabilities
$49.16 M
+$9.49 M+23.91%
December 31, 2023
Summary
- As of February 7, 2025, ATAI annual total liabilities is $49.16 million, with the most recent change of +$9.49 million (+23.91%) on December 31, 2023.
- During the last 3 years, ATAI annual total liabilities has risen by +$32.98 million (+203.84%).
- ATAI annual total liabilities is now at all-time high.
Performance
ATAI Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$51.20 M
+$3.96 M+8.38%
September 30, 2024
Summary
- As of February 7, 2025, ATAI quarterly total liabilities is $51.20 million, with the most recent change of +$3.96 million (+8.38%) on September 30, 2024.
- Over the past year, ATAI quarterly total liabilities has increased by +$11.49 million (+28.95%).
- ATAI quarterly total liabilities is now -68.18% below its all-time high of $160.91 million, reached on June 1, 2018.
Performance
ATAI Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
ATAI Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +23.9% | +28.9% |
| 3 y3 years | +203.8% | +74.3% |
| 5 y5 years | +1612.7% | +74.3% |
ATAI Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +74.3% | at high | +81.5% |
| 5 y | 5-year | at high | +1883.9% | at high | +216.5% |
| alltime | all time | at high | +1883.9% | -68.2% | +1683.8% |
Atai Life Sciences NV Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $51.20 M(+8.4%) |
| Jun 2024 | - | $47.24 M(+3.0%) |
| Mar 2024 | - | $45.86 M(-6.7%) |
| Dec 2023 | $49.16 M(+23.9%) | $49.16 M(+23.8%) |
| Sep 2023 | - | $39.71 M(+4.6%) |
| Jun 2023 | - | $37.96 M(-5.3%) |
| Mar 2023 | - | $40.08 M(+1.0%) |
| Dec 2022 | $39.67 M(+40.7%) | $39.67 M(-14.7%) |
| Sep 2022 | - | $46.52 M(+61.4%) |
| Jun 2022 | - | $28.81 M(-1.9%) |
| Mar 2022 | - | $29.38 M(+4.1%) |
| Dec 2021 | $28.21 M(+74.3%) | $28.21 M(+32.1%) |
| Sep 2021 | - | $21.35 M(+1.3%) |
| Jun 2021 | - | $21.07 M(-16.6%) |
| Mar 2021 | - | $25.27 M(+56.2%) |
| Dec 2020 | $16.18 M(+552.9%) | $16.18 M(-64.6%) |
| Sep 2020 | - | $45.76 M(+5.0%) |
| Jun 2020 | - | $43.56 M(-7.5%) |
| Mar 2020 | - | $47.12 M(+1.3%) |
| Dec 2019 | $2.48 M(-13.7%) | - |
| Dec 2019 | - | $46.53 M(-4.1%) |
| Sep 2019 | - | $48.50 M(+1547.8%) |
| Jun 2019 | - | $2.94 M(-22.4%) |
| Mar 2019 | - | $3.79 M(+32.1%) |
| Dec 2018 | $2.87 M(-88.8%) | $2.87 M(-72.9%) |
| Sep 2018 | - | $10.61 M(-93.4%) |
| Jun 2018 | - | $160.91 M(+256.3%) |
| Mar 2018 | - | $45.16 M(+167.3%) |
| Dec 2017 | $25.59 M(+38.4%) | - |
| Sep 2017 | - | $16.90 M(+16.0%) |
| Jun 2017 | - | $14.56 M(-21.2%) |
| Mar 2017 | $18.49 M(+56.8%) | $18.49 M(-2.7%) |
| Dec 2016 | - | $19.00 M(+11.8%) |
| Sep 2016 | - | $16.99 M(+58.3%) |
| Jun 2016 | - | $10.73 M(-8.9%) |
| Mar 2016 | $11.79 M | $11.79 M(-28.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2015 | - | $16.59 M(+11.9%) |
| Sep 2015 | - | $14.82 M(+29.5%) |
| Jun 2015 | - | $11.45 M(-8.8%) |
| Mar 2015 | $12.55 M(-1.8%) | $12.55 M(-10.0%) |
| Dec 2014 | - | $13.94 M(-27.9%) |
| Sep 2014 | - | $19.33 M(-13.6%) |
| Jun 2014 | - | $22.38 M(+75.0%) |
| Mar 2014 | $12.79 M(-3.4%) | $12.79 M(-34.3%) |
| Dec 2013 | - | $19.45 M(+66.4%) |
| Sep 2013 | - | $11.69 M(-28.6%) |
| Jun 2013 | - | $16.38 M(+23.8%) |
| Mar 2013 | $13.24 M(-11.3%) | $13.24 M(-17.5%) |
| Dec 2012 | - | $16.04 M(+2.2%) |
| Sep 2012 | - | $15.69 M(+23.0%) |
| Jun 2012 | - | $12.75 M(-14.6%) |
| Mar 2012 | $14.93 M(+37.4%) | $14.93 M(-7.5%) |
| Dec 2011 | - | $16.15 M(+26.1%) |
| Sep 2011 | - | $12.80 M(-38.3%) |
| Jun 2011 | - | $20.76 M(+91.0%) |
| Mar 2011 | $10.87 M(-10.5%) | $10.87 M(-8.2%) |
| Jun 2010 | - | $11.84 M(-2.5%) |
| Mar 2010 | $12.15 M(-8.9%) | $12.15 M(-10.3%) |
| Dec 2009 | - | $13.55 M(+11.2%) |
| Sep 2009 | - | $12.18 M(+5.9%) |
| Jun 2009 | - | $11.50 M(-13.7%) |
| Mar 2009 | $13.33 M(+26.9%) | $13.33 M(+25.6%) |
| Dec 2008 | - | $10.61 M(-18.4%) |
| Sep 2008 | - | $13.00 M(+34.3%) |
| Jun 2008 | - | $9.68 M(-7.9%) |
| Mar 2008 | $10.51 M(+51.6%) | $10.51 M(-7.5%) |
| Dec 2007 | - | $11.36 M(+27.4%) |
| Sep 2007 | - | $8.92 M(+28.6%) |
| Mar 2007 | $6.93 M(-11.2%) | $6.93 M |
| Mar 2006 | $7.80 M(-48.0%) | - |
| Mar 2004 | $15.00 M(+19.4%) | - |
| Dec 2003 | $12.56 M | - |
FAQ
- What is Atai Life Sciences NV annual total liabilities?
- What is the all time high annual total liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV annual total liabilities year-on-year change?
- What is Atai Life Sciences NV quarterly total liabilities?
- What is the all time high quarterly total liabilities for Atai Life Sciences NV?
- What is Atai Life Sciences NV quarterly total liabilities year-on-year change?
What is Atai Life Sciences NV annual total liabilities?
The current annual total liabilities of ATAI is $49.16 M
What is the all time high annual total liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high annual total liabilities is $49.16 M
What is Atai Life Sciences NV annual total liabilities year-on-year change?
Over the past year, ATAI annual total liabilities has changed by +$9.49 M (+23.91%)
What is Atai Life Sciences NV quarterly total liabilities?
The current quarterly total liabilities of ATAI is $51.20 M
What is the all time high quarterly total liabilities for Atai Life Sciences NV?
Atai Life Sciences NV all-time high quarterly total liabilities is $160.91 M
What is Atai Life Sciences NV quarterly total liabilities year-on-year change?
Over the past year, ATAI quarterly total liabilities has changed by +$11.49 M (+28.95%)